These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9722886)

  • 21. Signal for potyvirus-dependent aphid transmission of potato aucuba mosaic virus and the effect of its transfer to potato virus X.
    Baulcombe DC; Lloyd J; Manoussopoulos IN; Roberts IM; Harrison BD
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1245-53. PubMed ID: 8336116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The coat and cylindrical inclusion proteins of a potyvirus are associated with connections between plant cells.
    Rodríguez-Cerezo E; Findlay K; Shaw JG; Lomonossoff GP; Qiu SG; Linstead P; Shanks M; Risco C
    Virology; 1997 Sep; 236(2):296-306. PubMed ID: 9325237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of Tobacco etch virus coat protein mutants.
    Voloudakis AE; Malpica CA; Aleman-Verdaguer ME; Stark DM; Fauquet CM; Beachy RN
    Arch Virol; 2004 Apr; 149(4):699-712. PubMed ID: 15045558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A.
    Turner PC; Young DC; Flanegan JB; Moyer RW
    Virology; 1989 Dec; 173(2):509-21. PubMed ID: 2556841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1.
    Zhou JA; McIndoe A; Davies H; Sun XY; Crawford L
    Virology; 1991 Mar; 181(1):203-10. PubMed ID: 1847256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nucleotide sequence of the 3'-terminal region of dasheen mosaic virus (Caladium isolate) and expression of its coat protein in Escherichia coli for antiserum production.
    Li RH; Zettler FW; Purcifull DE; Hiebert E
    Arch Virol; 1998; 143(12):2461-9. PubMed ID: 9930202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
    Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
    J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
    Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
    J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poxvirus-based vectors as vaccine candidates.
    Tartaglia J; Pincus S; Paoletti E
    Crit Rev Immunol; 1990; 10(1):13-30. PubMed ID: 2407263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication slippage in the evolution of potyviruses.
    Hancock JM; Chaleeprom W; Chaleeprom W; Dale J; Gibbs A
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3229-32. PubMed ID: 8847535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation and epitope analysis of monoclonal antibodies to virions of clover yellow vein and Johnsongrass mosaic potyviruses.
    Hewish DR; Xiao XW; Mishra A; Gough KH; Shukla DD
    Arch Virol; 1993; 133(1-2):127-41. PubMed ID: 7694567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
    Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
    J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization and coat protein serology of watermelon leaf mottle virus (Potyvirus).
    De Sa PB; Hiebert E; Purcifull DE
    Arch Virol; 2000; 145(3):641-50. PubMed ID: 10795529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins.
    Himly M; Pfleiderer M; Holzer G; Fischer U; Hannak E; Falkner FG; Dorner F
    Protein Expr Purif; 1998 Dec; 14(3):317-26. PubMed ID: 9882565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein.
    Spehner D; Kirn A; Drillien R
    J Virol; 1991 Nov; 65(11):6296-300. PubMed ID: 1920633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assembly of double-layered virus-like particles in mammalian cells by coexpression of human rotavirus VP2 and VP6.
    González SA; Affranchino JL
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2357-60. PubMed ID: 7561777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible gene expression from vaccinia virus vectors.
    Rodriguez JF; Smith GL
    Virology; 1990 Jul; 177(1):239-50. PubMed ID: 2191497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of vaccinia virus in glioma model.
    Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
    Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine].
    Volz A; Fux R; Langenmayer MC; Sutter G
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):464-72. PubMed ID: 26697713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.